GCG and urinary bladder cancer: Metformin and thazolidinediones can be considered beneficial (with the exception of bladder cancer in the latter case); incretin drugs seem to be neutral, although they have potential for benefits, especially GLP-1 receptor agonists; while insulin, due to its mitogenic effect, should be used with caution.